Paragon Care Limited (ASX:PGC)

Market Cap	297.95M -67.3%
Revenue (ttm)	3.61B +21.7%
Net Income	20.57M +151.5%
EPS	0.01 +42.5%
Shares Out	1.66B
PE Ratio	14.52
Forward PE	9.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	445,590
Average Volume	857,757
Open	0.1850
Previous Close	0.1800
Day's Range	0.1850 - 0.1950
52-Week Range	0.1750 - 0.5500
Beta	1.42
RSI	28.98
Earnings Date	Feb 24, 2026

About Paragon Care

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, b...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2005
• Employees: 550
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PGC

Financial Performance

In fiscal year 2025, Paragon Care's revenue was 3.61 billion, an increase of 21.68% compared to the previous year's 2.97 billion. Earnings were 20.57 million, an increase of 151.52%.